| Literature DB >> 35745770 |
Zhen Li1,2, Shunqi Mei2, Yajie Dong1,2, Fenghua She1, Chengpeng Li3, Yongzhen Li3, Lingxue Kong1.
Abstract
Chitosan (CS) is a biodegradable, biocompatible, and non-toxic natural amino-poly-saccharide with antibacterial ability, owing to its positively charged amino groups. However, the low charge density leads to poor antibacterial efficiency which cannot meet the biomedical application requirements. In this study, Tobramycin (TOB) was grafted onto the backbone of oxidized chitosan (OCS) to synthesize oxidized chitosan-tobramycin (OCS-TOB). FTIR, 1H NMR and elemental analysis results demonstrated that OCS-TOB was successfully synthesized. OCS-TOB/PEO composite fibrous materials were produced by a self-made centrifugal spinning machine. In vitro experiments showed that cells proliferated on the submicro-fibrous OCS-TOB/PEO of appropriate concentration, and the antibacterial ability of OCS-TOB was much improved, compared with pristine CS. The results demonstrated that OCS-TOB/PEO nanofibrous materials could potentially be used for biomedical applications.Entities:
Keywords: biomedical application; centrifugal spinning; chitosan; submicro-fibers; tobramycin
Year: 2022 PMID: 35745770 PMCID: PMC9227200 DOI: 10.3390/pharmaceutics14061197
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.525
Figure 1Synthesis of OCS-TOB procedures (a); FTIR curves (b) and 1H NMR spectrum (c) of CS, OCS and OCS-TOB.
Mass percentage of C and N in CS, OCS and OCS-TOB.
| Samples | C (%) | N (%) | C/N |
|---|---|---|---|
| CS | 41.8 | 7.59 | 5.51 |
| OCS | 36.23 | 6.48 | 5.59 |
| OCS-TOB | 37.90 | 5.52 | 6.87 |
Figure 2Virtual model and the corresponding optical photo of self-designed centrifugal spinning equipment (a1,a2,b); the viscosities of three different ratios of OCS-TOB/PEO solutions change with shear rate (c); SEM images of OCS-TOB/PEO sub micro-fibers with different ratios of solutions with corresponding fiber diameter distribution, 1:2 OCS-TOB/PEO (d1,d2), 1:3 OCS-TOB/PEO (e1,e2) and 1:4 OCS-TOB/PEO (f1,f2), the scale bar is 5 μm.
Figure 3The TGA results of different ratios of OCS-TOB/PEO composite sub micro-fibers (a); mechanical test of the produced OCS-TOB/PEO sub micro-fiber yarn (b); the contact angle test of different ratios of OCS-TOB/PEO sub micro-fiber mats: 1:2 OCS-TOB/PEO (c), 1:3 OCS-TOB/PEO (d) and 1:4 OCS-TOB/PEO (e).
Figure 4Cell viability of 1:2 OCS-TOB/PEO and 1:4 OCS-TOB/PEO in 24 h (a); inhibition effect of CS, WSCS and OCS-TOB against E. coli (b) and S. aureus (c); and inhibition effect of different ratios of OCS-TOB/PEO sub micro-fibers against E. coli (d) and S. aureus (e). Scale bar is 5 mm.
Average inhibition sizes of CS, WSCS, OCS-TOB and different ratios of OCS-TOB/PEO sub micro-fibers against E. coli and S. aureus.
| Drug | Average Diameter of Inhibition Zone (mm) | Standard Deviation | ||
|---|---|---|---|---|
|
|
|
|
| |
| CS | 9.55 | 8.91 | 0.31 | 0.36 |
| WSCS | - | - | - | - |
| OCS-TOB | 19.49 | 18.66 | 0.26 | 0.28 |
| 1:2 OCS-TOB/PEO | 18.21 | 18.38 | 0.21 | 0.25 |
| 1:3 OCS-TOB/PEO | 18.17 | 18.07 | 0.22 | 0.23 |
| 1:4 OCS-TOB/PEO | 15.58 | 15.67 | 0.28 | 0.25 |
| Control | - | - | - | - |